Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

Cancer. 2011 Jun 1;117(11):2579-80; author reply 2580-1. doi: 10.1002/cncr.25784. Epub 2010 Dec 14.

Authors

Kacey O'Rourke¹, Kirk Morris, Glen A Kennedy

Affiliation

¹ Department of Haematology Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

PMID: 24048807
DOI: 10.1002/cncr.25784

No abstract available

Publication types

Letter
Comment

MeSH terms

Central Nervous System Neoplasms / prevention & control*
Central Nervous System Neoplasms / secondary*
Female
Humans
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Male
Methotrexate / administration & dosage*

Substances

Methotrexate